BankPlus Trust Department

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2047270 JACKSON, MS

Position in VRTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$639,891

+$25,135 QoQ

Shares Held

1,433

+5.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BankPlus Trust Department holds $651,170 across 4 Biotechnology names. VRTX ranks #1 (98.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,433	$639,891
2	NNVC	Nanoviricides, Inc.	7,000	$6,370
3	CRSP	CRISPR Therapeutics AG	100	$4,757
4	MRNA	Moderna, Inc.	3	$152

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$639,891	1,433	+5.7%	Shares	Sole	2026-05-11
2025-12-31	$614,756	1,356	+2.5%	Shares	Sole	2026-01-27
2025-09-30	$518,139	1,323	-1.3%	Shares	Sole	2025-10-17
2025-06-30	$597,013	1,341	-1.1%	Shares	Sole	2025-07-23
2025-03-31	$657,415	1,356	-1.7%	Shares	Sole	2025-05-01
2024-12-31	$555,323	1,379	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.